Skip to content
SeminarRecording availablePharmacology

Antisense oligonucleotide mediated exon skipping therapy development for Duchenne muscular dystrophy takes more than an oligonucleotide

Watch recording (opens in a new tab)
Annemieke Aartsma-Rus

Leiden University Medical Center, the Netherlands

Hosted by ERN-RND

· 70 minutes
ZA Leiden, Netherlands · Hybrid

Topics

advanced therapies

Related Seminars

Seminar

Targeting alternative splicing of SYNGAP1 using antisense oligonucleotides

Related research

Recording · Sep 29, 2022

We use cookies for analytics.